FOLH1 (PSMA) is a cell-surface glutamate carboxypeptidase highly expressed in prostate cancer, including metastatic castration-resistant disease. PSMA is a leading prostate cancer target for imaging, antibody therapy, and CAR-T.
| Catalog No. | Product Name | Conjugate | Size | Price (In USD) |
|---|---|---|---|---|
| GM-Tg-hg-T97071-Ab-3-PE | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(PE) | PE | 25T | |
| GM-Tg-hg-T97071-Ab-3-PE | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(PE) | PE | 100T | |
| GM-Tg-hg-T97071-Ab-3-PE | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(PE) | PE | 500T | |
| GM-Tg-hg-T97071-Ab-3-FITC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(FITC) | FITC | 25T | |
| GM-Tg-hg-T97071-Ab-3-FITC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(FITC) | FITC | 100T | |
| GM-Tg-hg-T97071-Ab-3-FITC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(FITC) | FITC | 500T | |
| GM-Tg-hg-T97071-Ab-3-APC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(APC) | APC | 25T | |
| GM-Tg-hg-T97071-Ab-3-APC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(APC) | APC | 100T | |
| GM-Tg-hg-T97071-Ab-3-APC | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(APC) | APC | 500T | |
| GM-Tg-hg-T97071-Ab-3-Biotin | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(Biotin) | Biotin | 25T, 100T, 500T |
| Target | PSMA (specific biomarker for human prostate cancer cell) |
|---|---|
| Species | Humanized |
| Expression platform | Mammalian cell |
| Isotypes | Human IgG |
| Tag | hFc |
| Conjugate | PE / FITC / APC / Biotin |
| Size | 25T / 100T / 500T |
| Purity | >=95% (SDS-PAGE) |
| Bioactivity validation | PSMA binding, FACS in PSMA level test |
| Application | FACS and other Immunoassay for PSMA test |
| Products description | Anti-Human PSMA/GCPII/FOLH1 monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes PSMA (prostate-specific membrane antigen over-expressed on prostate cancer). PSMA is a prostate cancer cell marker. This antibody is validated by FACS for prostate-cancer target assessment for PSMA CAR-T. It is recommended for multi-color flow cytometry panels to validate PSMA expression for prostate-cancer CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment. |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |